Anders Fuglsang

3PUBLICATIONS
0CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classifiedOncology and carcinogenesis not elsewhere classifiedLarge and complex data theory
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 16, 2024
Evaluation of Incurred Subject Period Re-analysis (ISPR) as a Tool to Distinguish Fraudulent Pharmacokinetic Profile Pairs from Non-fraudulent Pairs.

Anders Fuglsang, Anshul Dogra, Naveen Sharma

|Oct 31, 2021
Increased Patient's Risk Associated with the Canadian Bioequivalence Guidance Due to Outlier Removal.

Anders Fuglsang

|Jun 02, 2021
Mitigation of the convergence issues associated with semi-replicated bioequivalence data.

Anders Fuglsang

Pageof 1

Frequent Collaborators